Telomere shortening is a hallmark of genetic cardiomyopathies
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Significance: We find that telomere shortening, which usually accompanies cell division in the course of aging, occurs in cardiomyocytes (CMs) of individuals with genetic hypertrophic cardiomyopathy (HCM) or dilated cardiomyopathy (DCM). HCM and DCM CMs differentiated from human-induced pluripotent stem cells (hiPSCs) also exhibit significant telomere shortening relative to healthy controls. By contrast, no telomere shortening was detected in vascular smooth muscle cells in tissue or hiPSC-derived cells, a cell type that does not express the mutant proteins. Our findings provide evidence for accelerated aging in CMs with familial cardiomyopathy. The potential to monitor the dynamics of telomere attrition in hiPSC-CMs over time will enable future mechanistic studies and screens for novel therapeutic agents to arrest telomere shortening and disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1. HCM and DCM CMs exhibit telomere shortening. (A) Paraffin-embedded cardiac samples were used for telomere Q-FISH quantification of CMs. (B) Patient CMs [cardiac Troponin-T (green) indicated by white arrowhead] were stained for telomere (red) and for nuclear DAPI (blue) in patient and control cardiac tissue sections. (Scale bars, 10 μm.) Telomere levels were scored in a blinded fashion (n = 40–220 nuclei per patient tissue) within five to six regions of interest in two nonconsecutive sections, and (C) telomere signal intensity per DAPI-stained nucleus is plotted as mean ± SEM (*P < 0.05 and ****P < 0.0001).](https://figures.cochat.ai/paper-figures/be2be2616bac44a0a09f56c3991c3dfc/telomere-shortening-is-a-hallmark-of-genetic-cardiomyopathies-figure-1.jpg)
![Fig. 2. HCM and DCM VSMCs do not exhibit telomere shortening. (A) Paraffin-embedded cardiac samples were used for telomere Q-FISH quantification of VSMCs. (B) Patient VSMCs [smooth muscle actin (green) indicated by white arrowhead] were stained for telomere (red) and for nuclear DAPI (blue) in patient and control cardiac tissue sections. (Scale bars, 10 μm.) Telomere levels were scored in a blinded fashion (n = 30–150 nuclei per patient tissue) within three to four regions of interest in two nonconsecutive sections, and (C) telomere signal intensity per DAPI-stained nucleus is plotted as mean ± SEM.](https://figures.cochat.ai/paper-figures/2d1ad4c980004c4fb25d630753511e71/telomere-shortening-is-a-hallmark-of-genetic-cardiomyopathies-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Patients with genetic forms of hypertrophic or dilated cardiomyopathy, conditions that affect 1 in 500–2,500 people worldwide, have cardiomyocytes with shorter telomeres than age-matched individuals107,108.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [108]
The cited source says what the claim attributes to it.
In the citing paper
“Short telomeres have been observed in aged murine CMs (Rota et al, 2007) and in cardiomyocytes from individuals with end‐stage hypertrophic or dilated cardiomyopathy (Chang et al, 2018) and mouse models of accelerated telomere shortening exhibit cardiac dysfunction (Chang et al, 2016).”
From Length-independent telomere damage drives post-mitotic cardiomyocyte senescence (2019) · cites this paper as Chang et al, 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
Evidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130 · cited 2×
“In contrast to most cell types, in healthy postnatal cardiomyocytes (CMs), telomeres are largely maintained throughout life (4, 5), presumably because postnatal CMs are relatively nonproliferative (6).”
Truncations of titin causing dilated cardiomyopathy
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110186 · Cited by 1,485 · cited 7×
“Patient mutations included three genes associated with HCM [troponin I (TNNI3), cardiac myosin binding protein C (MYBPC3), and myosin heavy chain 7 (MYH7)] and three genes associated with DCM [dystrophin (DMD), cardiac troponin T (TNNT2), and titin (TTN)] (9–11).”
InfluentialSelf-citationTelomere length measurement by a novel monochrome multiplex quantitative PCR method
Cawthon, R. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1027 · Cited by 1,410
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319 · cited 2×
“These murine models suggest that a telomere–mitochondrial axis is key to maintaining cardiac function and, in its absence, dilated cardiomyopathy leading to heart failure ensues (22, 23).”
Tohyama, S., Hattori, F., Sano, M., Hishiki, T., Nagahata, Y., Matsuura, T., Hashimoto, H., Suzuki, T., Yamashita, H., Satoh, Y., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.09.013 · Cited by 1,037
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696 · cited 8×
“The TNNT2 DCM patient cardiac tissue sample and the HCM patient cardiac samples were obtained from explanted heart tissues from patients with end-stage cardiomyopathy just before heart transplantation at Stanford University.”
InfluentialSelf-citationBurridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
Self-citationLan, F., Lee, A. S., Liang, P., Sanchez-Freire, V., Nguyen, P. K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.010 · Cited by 667
Self-citationTitin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy
Hinson, J. T., Chopra, A., Nafissi, N., Polacheck, W. J., Benson, C. C., Swist, S., Gorham, J., Yang, L., Schafer, S., Sheng, C. C., et al. (2015) · Science · doi:10.1126/science.aaa5458 · Cited by 638
Self-citationX-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart
Prosser, B. L., Ward, C. W., & Lederer, W. J. (2011) · Science · doi:10.1126/science.1202768 · Cited by 564
Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall
Werner, C., Fürster, T., Widmann, T., Pöss, J., Roggia, C., Hanhoun, M., Scharhag, J., Büchner, N., Meyer, T., Kindermann, W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.861005 · Cited by 380 · cited 1×
“Telomerase activity is induced in mice that exercise (27), and overexpression of telomerase protein (TERT) in mouse CMs protects the animals from myocardial infarction (28, 29) by an unknown mechanism.”
Robin, J. D., Ludlow, A. T., Batten, K., Magdinier, F., Stadler, G., Wagner, K. R., Shay, J. W., & Wright, W. E. (2014) · Genes & Development · doi:10.1101/gad.251041.114 · Cited by 328
Telomere lengths are characteristic in each human individual
Takubo, K., Izumiyama-Shimomura, N., Honma, N., Sawabe, M., Arai, T., Kato, M., Oshimura, M., & Nakamura, K.-I. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00218-2 · Cited by 326
Oh, H., Taffet, G. E., Youker, K. A., Entman, M. L., Overbeek, P. A., Michael, L. H., & Schneider, M. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191169098 · Cited by 289
Telomere attrition and Chk2 activation in human heart failure
Oh, H., Wang, S. C., Prahash, A., Sano, M., Moravec, C. S., Taffet, G. E., Michael, L. H., Youker, K. A., Entman, M. L., & Schneider, M. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0836098100 · Cited by 197
Wu, H., Lee, J., Vincent, L. G., Wang, Q., Gu, M., Lan, F., Churko, J. M., Sallam, K. I., Matsa, E., Sharma, A., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.020 · Cited by 177
Self-citationAccelerated Telomere Shortening in Fibroblasts After Extended Periods of Confluency
Sitte, N. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00363-8 · Cited by 164
Bär, C., de Jesus, B. B., Serrano, R., Tejera, A., Ayuso, E., Jimenez, V., Formentini, I., Bobadilla, M., Mizrahi, J., de Martino, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6863 · Cited by 162 · cited 1×
“Telomerase activity is induced in mice that exercise (27), and overexpression of telomerase protein (TERT) in mouse CMs protects the animals from myocardial infarction (28, 29) by an unknown mechanism.”
Wanjare, M., Kuo, F. H., & Gerecht, S. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs315 · Cited by 156
Role of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Mourkioti, F., Kustan, J., Kraft, P., Day, J. W., Zhao, M.-M., Kost-Alimova, M., Protopopov, A., DePinho, R. A., Bernstein, D., Meeker, A. K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2790 · Cited by 136
Self-citationForce, T., Bonow, R. O., Houser, S. R., Solaro, R. J., Hershberger, R. E., Adhikari, B., Anderson, M. E., Boineau, R., Byrne, B. J., Cappola, T. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.950089 · Cited by 120
Self-citationCardiomyocyte‐Specific Telomere Shortening is a Distinct Signature of Heart Failure in Humans
Sharifi‐Sanjani, M., Oyster, N. M., Tichy, E. D., Bedi, K. C., Harel, O., Margulies, K. B., & Mourkioti, F. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005086 · Cited by 114
Postnatal telomere dysfunction induces cardiomyocyte cell-cycle arrest through p21 activation
Aix, E., Gutiérrez-Gutiérrez, Ó., Sánchez-Ferrer, C., Aguado, T., & Flores, I. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201510091 · Cited by 84
Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy
Chang, A. C. Y., Ong, S.-G., LaGory, E. L., Kraft, P. E., Giaccia, A. J., Wu, J. C., & Blau, H. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615340113 · Cited by 81 · cited 21×
“Sections (4 μm) from paraffin blocks were placed on ChemMate slides (Fisher Scientific) for telomere Q-FISH analyses as previously described (7, 8).”
InfluentialSelf-citationThe Young Mouse Heart Is Composed of Myocytes Heterogeneous in Age and Function
Rota, M., Hosoda, T., De Angelis, A., Arcarese, M. L., Esposito, G., Rizzi, R., Tillmanns, J., Tugal, D., Musso, E., Rimoldi, O., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.151449 · Cited by 75 · cited 1×
“Additionally, telomere lengths have been shown to be heterogeneous in cells of cardiac tissues of aged mice (20).”
Long telomeres protect against age-dependent cardiac disease caused by NOTCH1 haploinsufficiency
Theodoris, C. V., Mourkioti, F., Huang, Y., Ranade, S. S., Liu, L., Blau, H. M., & Srivastava, D. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90338 · Cited by 55
Self-citationAssociation of telomere shortening in myocardium with heart weight gain and cause of death
Terai, M., Izumiyama-Shimomura, N., Aida, J., Ishikawa, N., Sawabe, M., Arai, T., Fujiwara, M., Ishii, A., Nakamura, K.-I., & Takubo, K. (2013) · Scientific Reports · doi:10.1038/srep02401 · Cited by 46
The Mutations Associated with Dilated Cardiomyopathy
Parvari, R., & Levitas, A. (2012) · Biochemistry Research International · doi:10.1155/2012/639250 · Cited by 44
Cardiac telomere length in heart development, function, and disease
Booth, S. A., & Charchar, F. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00024.2017 · Cited by 39
Cited by
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Length-independent telomere damage drives post-mitotic cardiomyocyte senescence
Anderson, R., Lagnado, A., Maggiorani, D., Walaszczyk, A., Dookun, E., Chapman, J., Birch, J., Salmonowicz, H., Ogrodnik, M., Jurk, D., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100492 · Cited by 532
“…Short telomeres have been observed in aged murine CMs (Rota et al , 2007) and in cardiomyocytes from individuals with end-stage hypertrophic or dilated cardiomyopathy (Chang et al , 2018) and mouse models of accelerated telomere shortening exhibit cardiac dysfunction (Chang et al , 2016).”
Su, M., Xiao, Y., Ma, J., Tang, Y., Tian, B., Zhang, Y., Li, X., Wu, Z., Yang, D., Zhou, Y., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1002-6 · Cited by 457
Mechanosensing by the Lamina Protects against Nuclear Rupture, DNA Damage, and Cell-Cycle Arrest
Cho, S., Vashisth, M., Abbas, A., Majkut, S., Vogel, K., Xia, Y., Ivanovska, I. L., Irianto, J., Tewari, M., Zhu, K., et al. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.020 · Cited by 297
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Metadata
- Authors
- Chang, A. C. Y., Chang, A. C. H., Kirillova, A., Sasagawa, K., Su, W., Weber, G., Lin, J., Termglinchan, V., Karakikes, I., Seeger, T., Dainis, A. M., Hinson, J. T., Seidman, J., Seidman, C. E., Day, J. W., Ashley, E., Wu, J. C., & Blau, H. M.
- Affiliations
- Stanford Medicine (US)
- University of California, San Francisco (US)
- Stanford Cardiovascular Institute (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Stanford University (US)
- Corresponding author
- Chang, Alex C. Y.
- Blau, Helen M.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-08-27
- Volume
- 115
- Issue
- 37
- Pages
- 9276-9281
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6140486
- OpenAlex
- W2889508731
- Cited by
- 91
- References
- 31
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 15 · 2023: 8 · 2022: 23 · 2021: 9 · 2020: 6 · 2019: 10
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Heart Association (13POST14480004 and 18CDA34110411, 15BGIA22730027, 17MERIT33610009, 17CSA33590101)
- Gouvernement du Canada | Canadian Institutes of Health Research (201411MFE-338745-169197)
- Burroughs Wellcome Fund (1015009)
- HHS | National Institutes of Health (K99 HL104002, K08 HL125807, R01 HL126527, R01 HL130020, R01 HL123968, and R24 HL117756, AG044815 and AR063963)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- telomere shortening, familial cardiomyopathy, hypertrophic cardiomyopathy, dilated cardiomyopathy, human induced pluripotent stem cells, cardiomyocytes, disease modeling, drug discovery
- MeSH terms
- Cardiomyopathy, Dilated, Cell Division, Female, Humans, Male, Muscle Proteins, Mutation, Cardiomyopathy, Hypertrophic, Familial, Induced Pluripotent Stem Cells, Telomere Shortening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.